UAB’s Director Of Infectious Diseases Warns Caution Around COVID-19 Vaccines In Trial

 ========= Old Image Removed =========1Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2020/09/Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425.png
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:5:{s:5:"width";i:901;s:6:"height";i:506;s:4:"file";s:63:"2020/09/Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425.png";s:5:"sizes";a:12:{s:6:"medium";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-336x189.png";s:5:"width";i:336;s:6:"height";i:189;s:9:"mime-type";s:9:"image/png";}s:5:"large";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-771x433.png";s:5:"width";i:771;s:6:"height";i:433;s:9:"mime-type";s:9:"image/png";}s:9:"thumbnail";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-140x140.png";s:5:"width";i:140;s:6:"height";i:140;s:9:"mime-type";s:9:"image/png";}s:12:"medium_large";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-768x431.png";s:5:"width";i:768;s:6:"height";i:431;s:9:"mime-type";s:9:"image/png";}s:9:"wbhm-icon";a:4:{s:4:"file";s:61:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-80x80.png";s:5:"width";i:80;s:6:"height";i:80;s:9:"mime-type";s:9:"image/png";}s:13:"wbhm-featured";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-800x450.png";s:5:"width";i:800;s:6:"height";i:450;s:9:"mime-type";s:9:"image/png";}s:20:"wbhm-featured-square";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-600x506.png";s:5:"width";i:600;s:6:"height";i:506;s:9:"mime-type";s:9:"image/png";}s:18:"wbhm-featured-home";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-554x311.png";s:5:"width";i:554;s:6:"height";i:311;s:9:"mime-type";s:9:"image/png";}s:22:"wbhm-featured-carousel";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-470x265.png";s:5:"width";i:470;s:6:"height";i:265;s:9:"mime-type";s:9:"image/png";}s:28:"ab-block-post-grid-landscape";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-600x400.png";s:5:"width";i:600;s:6:"height";i:400;s:9:"mime-type";s:9:"image/png";}s:25:"ab-block-post-grid-square";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-600x506.png";s:5:"width";i:600;s:6:"height";i:506;s:9:"mime-type";s:9:"image/png";}s:14:"post-thumbnail";a:4:{s:4:"file";s:63:"Screen_Shot_2020-09-03_at_4.20.52_PM-e1599173094425-125x125.png";s:5:"width";i:125;s:6:"height";i:125;s:9:"mime-type";s:9:"image/png";}}s:10:"image_meta";a:12:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";s:11:"orientation";s:1:"0";s:8:"keywords";a:0:{}}}
        )

    [_wp_attachment_backup_sizes] => Array
        (
            [0] => a:13:{s:9:"full-orig";a:3:{s:5:"width";i:901;s:6:"height";i:568;s:4:"file";s:40:"Screen_Shot_2020-09-03_at_4.20.52_PM.png";}s:14:"thumbnail-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-140x140.png";s:5:"width";i:140;s:6:"height";i:140;s:9:"mime-type";s:9:"image/png";}s:11:"medium-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-336x212.png";s:5:"width";i:336;s:6:"height";i:212;s:9:"mime-type";s:9:"image/png";}s:17:"medium_large-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-768x484.png";s:5:"width";i:768;s:6:"height";i:484;s:9:"mime-type";s:9:"image/png";}s:10:"large-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-771x486.png";s:5:"width";i:771;s:6:"height";i:486;s:9:"mime-type";s:9:"image/png";}s:14:"wbhm-icon-orig";a:4:{s:4:"file";s:46:"Screen_Shot_2020-09-03_at_4.20.52_PM-80x80.png";s:5:"width";i:80;s:6:"height";i:80;s:9:"mime-type";s:9:"image/png";}s:18:"wbhm-featured-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-800x450.png";s:5:"width";i:800;s:6:"height";i:450;s:9:"mime-type";s:9:"image/png";}s:25:"wbhm-featured-square-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-600x568.png";s:5:"width";i:600;s:6:"height";i:568;s:9:"mime-type";s:9:"image/png";}s:23:"wbhm-featured-home-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-493x311.png";s:5:"width";i:493;s:6:"height";i:311;s:9:"mime-type";s:9:"image/png";}s:27:"wbhm-featured-carousel-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-420x265.png";s:5:"width";i:420;s:6:"height";i:265;s:9:"mime-type";s:9:"image/png";}s:33:"ab-block-post-grid-landscape-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-600x400.png";s:5:"width";i:600;s:6:"height";i:400;s:9:"mime-type";s:9:"image/png";}s:30:"ab-block-post-grid-square-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-600x568.png";s:5:"width";i:600;s:6:"height";i:568;s:9:"mime-type";s:9:"image/png";}s:19:"post-thumbnail-orig";a:4:{s:4:"file";s:48:"Screen_Shot_2020-09-03_at_4.20.52_PM-125x125.png";s:5:"width";i:125;s:6:"height";i:125;s:9:"mime-type";s:9:"image/png";}}
        )

    [_media_credit] => Array
        (
            [0] => UAB's Facebook Page
        )

    [_navis_media_credit_org] => Array
        (
            [0] => 
        )

    [_navis_media_can_distribute] => Array
        (
            [0] => 1
        )

)
1659824199 
1599155181

Dr. Jeanne Marrazzo speaks during a press conference September 3, 2020.

UAB's Facebook Page

The director of infectious diseases at the University of Alabama at Birmingham says right now she would not take one of the COVID-19 vaccines currently in phase three clinical trials across the country.

During a press conference Thursday, Dr. Jeanne Marrazzo addressed the Centers for Disease Control’s announcement that a vaccine could be ready by the end of October. She said the vaccines have been fast-tracked and not much is known about their long term effects or success rates.

“Yes, I know there’s urgency, but we should not sacrifice our convenience for the rush to get a product that we just don’t know is really truly safe,” Marrazzo said. “We deserve the best. We deserve better. I mean people have been through hell with this thing.”

Efficacy trials, or better known as phase three trials, help determine if a vaccine works. In the case of COVID-19, for a phase three trial to be successful it must show that the vaccine reduces the number of actual infections in people and that participants are able to make antibodies against the virus over time.

But now, Marrazzo said, those efficacy standards may change with the release of data from a vaccine trial in the United Kingdom earlier this week.

“My big concern about this timeline that’s now out there is that not only do we not have the kind of evidence for efficacy, yet. Yet. I’m saying yet because maybe they know something I don’t know. That’s always possible,” Marrazzo said. “But do we really have confidence that we can go out there and vaccinate everybody safely without knowing the longer-term benefits or side effects of this vaccine?”

Marrazzo said she is also concerned that there is not enough information yet about long-lasting immunity to COVID-19, especially given recent reports of people being reinfected with the virus. She noted that the vaccines are based on a totally new technology.

“We have never had a messenger RNA vaccine in a human population before these trials,” Marrazzo said. “We think it’s safe, but we don’t know.”

She added that vaccines can have serious side effects. Marrazzo said phase three trials typically follow participants for at least a year, if not longer, to track possible side effects. If a vaccine is released in late October, it would have only been studied in humans for eight months – at most.

“We need iron-clad proof and assurance to the extent that anybody can get it in any vaccine study or any medical study that whatever product we make widely available to our citizens is as safe and effective as humanly possible,” Marrazzo said. “We are not there, right now. There’s no way I have seen, myself, and I know that most experts have seen enough data to feel like not only today there’s something to roll out but in seven short weeks … that there would be something to roll out.”

Marrazzo said ultimately the decision to get the vaccine is a risk-benefit analysis, but she will not get one unless it is backed by the Advisory Committee on Immunization Practices. Meanwhile, Marrazzo said she plans on volunteering for a vaccine clinical trial.

Editor’s Note: UAB holds WBHM’s broadcast license, but our news and business departments operate independently.

 

A zoo in Denmark asked patrons to donate their pets. Not as attractions, but for food

The Aalborg Zoo in Denmark said it would take certain surplus pets such as chickens, rabbits and guinea pigs to be "gently euthanized" and fed to its captive predators.

Public health experts dismayed by RFK Jr.’s defunding of mRNA vaccine research

The Trump administration cancelled about $500 million for research into mRNA vaccines. The move slows progress in using the technology to prevent a future pandemic or treat disease, experts say.

5 soldiers are shot at Georgia’s Fort Stewart. A suspect is in custody

The Army says that law enforcement was dispatched to the 2nd Armored Brigade Combat Team area at 10:56 a.m. local time and that the "shooter was apprehended at 11:35 a.m." No fatalities were reported.

The quest to create gene-edited babies gets a reboot 

There's a fresh push to edit the genes of human embryos to prevent diseases and enhance characteristics that parents value. Bioethicists say just because it's possible doesn't mean it should be done.

Claire’s, the ear-piercing tween mall staple, is bankrupt — again

The chain's bankruptcy filing is the second in seven years. Its troubles include unwieldy debt, shoppers' changing habits and new tariff costs.

White House envoy Witkoff meets with Putin as deadline looms for Russia to end war

White House envoy Steve Witkoff met Russian President Vladimir Putin in Moscow in a last-ditch effort to convince him to make peace in Ukraine or face punishing new economic penalties by Friday.

More Coronavirus Coverage